TSVT — 2Seventy Bio Share News
0.000.00%
Last trade - 00:00- $265.62m
- $95.24m
- $37.86m
U.S. STOCKS ON THE MOVE-Vera Bradley, Shake Shack, 2seventy Bio
2seventy bio climbs on Engine Capital's push for changes in company
Engine Capital pushes for changes at cancer therapy developer 2seventy bio (updated)
Brief: Engine Capital Sends Letter To 2Seventy’S Board Of Directors Outlining Steps To Maximize Shareholder Value
Engine Capital urges 2seventy bio to appoint finance chief Baird as CEO
US FDA investigating safety risk of CAR-T cancer therapies (updated)
U.S. STOCKS ON THE MOVE-Zoom Video, HP Inc, Boeing
U.S. STOCKS ON THE MOVE-Kohl's, Bristol-Myers Squibb, 2Seventy Bio
U.S. STOCKS ON THE MOVE-MediciNova, PENN Entertainment, Medtronic
2seventy bio slides as FDA may delay decision on cancer therapy
US FDA may delay decision on Bristol Myers-2seventy bio cancer therapy (updated)
US FDA delays decision on Bristol Myers-2seventy bio cancer therapy
U.S. RESEARCH ROUNDUP-Beauty Health, Design Therapeutics, Energizer Holdings
2seventy bio falls after co says it does not expect to meet annual sales target
Brief: 2Seventy Bio Q3 Basic EPS USD -1.4
2Seventy Bio Inc expected to post a loss of $1.03 a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Caterpillar, Intel, Yelp
Brief: 2seventy bio Says Abecma Generated About $69 Mln In Q3 U.S. Revenue
U.S. STOCKS ON THE MOVE-First Solar, Canadian Solar